Fibrosing cholestatic hepatitis is an aggressive and usually fatal form of
viral hepatitis in immunosuppressed patients. We report three cases of fibr
osing cholestatic hepatitis in various clinical situations. Case 1 was a 50
-year-old man who underwent a liver transplant for hepatitis B virus (HBV)-
associated liver cirrhosis. Two and a half years after the transplant, I-re
complained of fever and jaundice, and liver enzymes were slightly elevated
. Serum HBsAg was positive. Case 2 was a 30-year-old man in an immunosuppre
ssed state after chemotherapy for acute lymphoblastic leukemia. He was a HB
V carrier. Liver enzymes and total bilirubin were markedly elevated. Case 3
was a 50-year-old man who underwent renal transplantation as a known HBV c
arrier. One year Received: 15 April 1999 after the transplant, jaundice dev
eloped abruptly, but liver enzymes were not Accepted: 26 July 1999 signific
antly elevated. Microscopically lobules were markedly disarrayed, showing b
allooning degeneration of hepatocytes, prominent pericellular fibrosis, and
marked canalicular or intracytoplasmic cholestasis. Portal inflammation wa
s mild, but interphase activity was definite and cholangiolar proliferation
was prominent. Hepatocytes were diffusely positive for HBsAg and HBcAg in
various patterns. Patients died of liver failure within 1 to 3 months after
liver biopsy in spite of anti-viral treatment.